Celestica Inc. (TSE:CLS – Get Free Report) (NYSE:CLS) Director Michael M. Wilson sold 5,100 shares of Celestica stock in a transaction on Monday, January 6th. The shares were sold at an average price of C$141.77, for a total value of C$723,030.57.
Celestica Stock Up 4.6 %
Shares of TSE:CLS opened at C$147.42 on Thursday. Celestica Inc. has a 12-month low of C$36.08 and a 12-month high of C$148.59. The company has a current ratio of 1.47, a quick ratio of 0.54 and a debt-to-equity ratio of 52.78. The firm has a market cap of C$17.48 billion, a PE ratio of 34.93, a price-to-earnings-growth ratio of 0.14 and a beta of 2.23. The company has a fifty day simple moving average of C$125.61 and a 200 day simple moving average of C$91.72.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on CLS. Barclays raised Celestica to a “strong-buy” rating in a research note on Tuesday, November 5th. UBS Group upgraded shares of Celestica to a “hold” rating in a research note on Friday, November 22nd.
Celestica Company Profile
Celestica Inc provides supply chain solutions in North America, Europe, and Asia. It operates through two segments: Advanced Technology Solutions, and Connectivity & Cloud Solutions. The company offers a range of product manufacturing and related supply chain services, including design and development, new product introduction, engineering services, component sourcing, electronics manufacturing and assembly, testing, complex mechanical assembly, systems integration, precision machining, order fulfillment, logistics, asset management, product licensing, and after-market repair and return services.
Recommended Stories
- Five stocks we like better than Celestica
- The 3 Best Fintech Stocks to Buy Now
- Warren Buffett Bets on the Digital Economy With New VeriSign Buy
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Discover 2 Under-the-Radar Aerospace Stocks Set for 2025 Growth
- Which Wall Street Analysts are the Most Accurate?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
Receive News & Ratings for Celestica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celestica and related companies with MarketBeat.com's FREE daily email newsletter.